Microarray Standardization Efforts Targeting Clinic, But Not Broad Platform Interoperability | GenomeWeb

A number of standardization efforts are crawling through multiple ongoing consensus-building initiatives as the microarray industry and its 10-year-old technology eyes entering the $20 billion-a-year molecular diagnostics marketplace.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.